Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_assertion type Assertion NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_head.
- NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_assertion description "[We have shown that preoperative plasma levels of transforming growth factor-beta(1) (TGF-beta(1)), interleukin 6 (IL)-6, and its receptor (IL-6sR) are associated with prostate cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_provenance.
- NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_assertion evidence source_evidence_literature NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_provenance.
- NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_assertion SIO_000772 15041717 NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_provenance.
- NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_assertion wasDerivedFrom befree-20140225 NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_provenance.
- NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_assertion wasGeneratedBy ECO_0000203 NP551056.RArsn-X3l0EGgsLfDNyz56P8m7u_ALv1uA4jZ7U6-GTts130_provenance.